Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-24-136391

Director bought 12,500 shares at $7.93 ($99,084)

From the SEC's structured data for this filing

Trades in this filing

KARBE FRANK · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-13 Purchase : show line 1 in the form +12,500 $7.93 $99,084 57,000 D
Open-market purchases · 12,500 sh · avg $7.93 · $99,084
Loading xslF345X05/ownership.xml…